While exceptional internal research strength remains a hallmark of our success, AstraZeneca is actively seeking external opportunities to complement our existing capabilities.
Success is driven by people, and we take pride in having people that are open and responsive – the type of people that our partners want to work with. We believe that people and relationships ultimately determine the success of any partnership and we are committed to being transparent and responsive with all of our collaborators.
Contacts
For specific therapeutic opportunities please see contact details under respective areas of partnering interests. For general inquiries please contact
For information about biologics-related partnering opportunities, which are handled by MedImmune our global biologics unit please contact Sun Park or Ravi Venkataramani
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 03:38 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
